Edition:
United States

Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

16.26USD
12:51pm EST
Change (% chg)

$-0.35 (-2.11%)
Prev Close
$16.61
Open
$15.72
Day's High
$16.39
Day's Low
$15.55
Volume
196,154
Avg. Vol
403,901
52-wk High
$20.76
52-wk Low
$6.75

Chart for

About

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive... (more)

Overall

Beta: 1.92
Market Cap(Mil.): $1,895.60
Shares Outstanding(Mil.): 114.12
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.20 16.04
EPS (TTM): -- -- --
ROI: -- 15.06 34.69
ROE: -- 16.55 15.46

BRIEF-Corcept Therapeutics posts Q3 earnings per share $0.11

* Corcept Therapeutics announces third quarter 2017 financial results, raises 2017 revenue guidance and provides corporate update

Nov 02 2017

BRIEF-Corcept Therapeutic says Dohmen Life Science Services filed a complaint alleging Corcept unlawfully terminated Dohmen agreement

* Corcept Therapeutics Inc - On August 7, 2017, Dohmen Life Science Services filed a complaint alleging corcept unlawfully terminated dohmen agreement

Aug 30 2017

BRIEF-Corcept Therapeutics Q2 GAAP earnings per share $0.10

* Corcept Therapeutics announces second quarter 2017 financial results, raises 2017 revenue guidance and provides corporate update

Aug 01 2017

Competitors

Earnings vs. Estimates